146 related articles for article (PubMed ID: 37984359)
21. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
22. Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor.
Han J; Liu G; Profirovic J; Niu J; Voyno-Yasenetskaya T
FASEB J; 2009 Dec; 23(12):4193-206. PubMed ID: 19690217
[TBL] [Abstract][Full Text] [Related]
23. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.
Lin Y; Wozniak JM; Grimsey NJ; Girada S; Patwardhan A; Molinar-Inglis O; Smith TH; Lapek JD; Gonzalez DJ; Trejo J
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5039-5048. PubMed ID: 32071217
[TBL] [Abstract][Full Text] [Related]
24. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.
Bae JS; Rezaie AR
Thromb Haemost; 2008 Jul; 100(1):101-9. PubMed ID: 18612544
[TBL] [Abstract][Full Text] [Related]
25. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.
Yang Y; Stang A; Schweickert PG; Lanman NA; Paul EN; Monia BP; Revenko AS; Palumbo JS; Mullins ES; Elzey BD; Janssen EM; Konieczny SF; Flick MJ
Cancer Res; 2019 Jul; 79(13):3417-3430. PubMed ID: 31048498
[TBL] [Abstract][Full Text] [Related]
26. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells.
Bae JS; Yang L; Rezaie AR
J Thromb Haemost; 2008 Jun; 6(6):954-61. PubMed ID: 18284602
[TBL] [Abstract][Full Text] [Related]
27. Specificity of coagulation factor signaling.
Ruf W; Dorfleutner A; Riewald M
J Thromb Haemost; 2003 Jul; 1(7):1495-503. PubMed ID: 12871285
[TBL] [Abstract][Full Text] [Related]
28. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
Kaufmann R; Rahn S; Pollrich K; Hertel J; Dittmar Y; Hommann M; Henklein P; Biskup C; Westermann M; Hollenberg MD; Settmacher U
J Cell Physiol; 2007 Jun; 211(3):699-707. PubMed ID: 17323377
[TBL] [Abstract][Full Text] [Related]
29. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
[TBL] [Abstract][Full Text] [Related]
30. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.
Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS
J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
32. Phloretin suppresses thrombin-mediated leukocyte-platelet-endothelial interactions.
Kim MS; Park SH; Han SY; Kim YH; Lee EJ; Yoon Park JH; Kang YH
Mol Nutr Food Res; 2014 Apr; 58(4):698-708. PubMed ID: 24338998
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory role of thrombin in cancer progression.
Alexander ET; Gilmour SK
Mol Carcinog; 2022 Jun; 61(6):527-536. PubMed ID: 35338515
[TBL] [Abstract][Full Text] [Related]
34. Amplification of protease-activated receptors signaling in sporadic cerebral cavernous malformation endothelial cells.
Scimone C; Alibrandi S; Donato L; De Gaetano GV; Fusco C; Nardella G; Castori M; Rinaldi C; Alafaci C; Germanò A; D'Angelo R; Sidoti A
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119474. PubMed ID: 37030452
[TBL] [Abstract][Full Text] [Related]
35. Thrombin domains: structure, function and interaction with platelet receptors.
De Cristofaro R; De Candia E
J Thromb Thrombolysis; 2003 Jun; 15(3):151-63. PubMed ID: 14739624
[TBL] [Abstract][Full Text] [Related]
36. Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4-Mediated Thrombin Resistance.
Gnanenthiran SR; Pennings GJ; Reddel CJ; Campbell H; Kockx M; Hamilton JR; Chen VM; Kritharides L
Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):960-972. PubMed ID: 35708029
[TBL] [Abstract][Full Text] [Related]
37. Multifunctional roles of thrombin.
Narayanan S
Ann Clin Lab Sci; 1999; 29(4):275-80. PubMed ID: 10528826
[TBL] [Abstract][Full Text] [Related]
38. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
[TBL] [Abstract][Full Text] [Related]
39. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells.
Zhang JJ; Kelm RJ; Biswas P; Kashgarian M; Madri JA
J Cell Physiol; 2007 Feb; 210(2):527-37. PubMed ID: 17111362
[TBL] [Abstract][Full Text] [Related]
40. Expression of prothrombin, thrombin and its receptors in human scars.
Artuc M; Hermes B; Algermissen B; Henz BM
Exp Dermatol; 2006 Jul; 15(7):523-9. PubMed ID: 16761961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
